Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma

Published:2020-07-14 Issue:17 Volume:9 Page:6344-6353
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Richard Sophie¹²,Tachon Gaëlle¹²³^ORCID,Milin Serge⁴,Wager Michel²³⁵,Karayan‐Tapon Lucie¹²³

Affiliation:

1. Faculté de Médecine Université de Poitiers Poitiers France

2. Laboratoire de cancérologie biologique CHU de Poitiers Poitiers France

3. Laboratoire des Neurosciences Expérimentales et Cliniques INSERM 1084 Poitiers France

4. Laboratoire d’anatomopathologie CHU de Poitiers Poitiers France

5. CHU de Poitiers Poitiers France

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3217

Reference43 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

2. Central nervous system gliomas

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

5. Newly diagnosed glioblastoma: a review on clinical management;Lukas RV;Oncol Williston Park N,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients;2024-09-08

2. A Synopsis of Biomarkers in Glioblastoma: Past and Present;Current Issues in Molecular Biology;2024-07-03

3. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy;Frontiers in Immunology;2024-01-11

4. Advancements in Glioma Care: Focus on Emerging Neurosurgical Techniques;Biomedicines;2023-12-20

5. Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play;Pathology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3